GBP510 with AS03 adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GBP510 with AS03 adjuvant, covering 2022-05-10 to 2022-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Study of SARS-CoV-2 Nanoparticle Vaccine (GBP510) Adjuvanted With or Without AS03 (COVID-19) [Phase 1, Phase 2]